A structured MedTech product acceleration platform taking biomedical innovations from early-stage prototypes to regulatory-cleared, deployment-ready products — anchored at IKP Knowledge Park's Hyderabad and Bengaluru campuses and funded by Blockchain for Impact (BFI).
India imports nearly 70% of its medical devices by value, and close to 80% of MedTech startups fail between Technology Readiness Levels (TRL) 3 and 6 — not for lack of innovation, but for lack of the infrastructure, expertise, and institutional support required to navigate the build.
BFI NAMAH at IKP is a direct institutional response to that gap. The Nailwal MedTech Acceleration Hub, a core programme under BFI's Innovation Full Stack, is anchored at IKP Knowledge Park — leveraging IKP's SmartFab product realization infrastructure, the IKP Global Regulatory Forum (IGRF), IKP COMPASS — Compliance-as-a-Service, and a mature network of clinical, testing, and manufacturing partners.
The programme adopts a milestone-driven, stage-gated approach to systematically de-risk product development — enabling innovators to move from prototype to regulatory approval with clarity, speed, and confidence.
Technology Readiness Levels define the progression of medical technologies from ideation to commercial deployment. The mid-TRL phase is the most demanding — requiring design refinement, validation, regulatory readiness, and pilot manufacturing. NAMAH operates across this critical span, advancing innovations toward pre-commercialisation and market entry.
Accepted innovators gain access to a comprehensive ecosystem built for end-to-end MedTech translation:
Rapid prototyping across mechanical, electronics, and biomedical domains — 3D printing, CNC machining, PCB assembly, injection moulding, and an ISO 7 clean room biomedical lab.
CAD modelling, simulation, and DFM strategy to move designs from prototype to production-ready — scaling to batch and low-volume manufacturing.
Structured guidance through CDSCO, MDR 2017, device classification, MD-12/MD-13 applications, and licensing — via the IKP Global Regulatory Forum (IGRF) and IKP COMPASS — Compliance-as-a-Service.
Early implementation of QMS, risk management (ISO 14971), biocompatibility (ISO 10993), DHF/DMR documentation, and GMP readiness.
Access to NABL-accredited labs, EMI/EMC test centres, BIS certification pathways, and standardized pre-clinical validation protocols.
Connections to hospitals, clinicians, and medical college incubation centres for clinical evaluation, pilot studies, and real-world validation.
IP landscaping, prior-art searches, patentability assessments, and technology transfer guidance from the earliest stages.
Dedicated technical handholding from engineers, regulatory specialists, and translational experts across the product journey.
Market access, manufacturing partnerships, fundraising, and investor connect through IKP's structured commercialisation network.
NAMAH prioritises high-impact domains where India has strong unmet clinical needs, high import dependence, and clear opportunities for translation and scale-up.
NAMAH supports innovators from academia, startups, hospitals, and independent innovation across the country, selected through a fair, structured process.
The programme is steered by a joint IKP–BFI Governing Panel, supported by independent domain experts, responsible for applicant selection and support decisions.
CEO, IKP Knowledge ParkRepresenting IKP
SVP & CEO, IKP EDENRepresenting IKP
Programme Director, BFI NAMAHRepresenting BFI
Programme Principal, BFI NAMAHRepresenting BFI
Dean, St John's Research InstituteIndependent Member
CEO, CHARAKA — CoE MedTech, Government of KarnatakaIndependent Member
Partner, Emdiya PartnersIndependent Member — VC Partner (proposed)
Programme LeadMember Secretary, Governing Panel
IKP Knowledge Park, Genome Valley, Shamirpet, Hyderabad
IKP EDEN, 16, Bhuvanappa Layout, Tavarekere Main Road, Bengaluru, Karnataka